MONTE ROSA THERAPEUTICS INC's ticker is GLUE and the CUSIP is 61225M102. A total of 74 filers reported holding MONTE ROSA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $165,854 | -14.0% | 34,625 | +23.0% | 0.00% | – |
| Q2 2023 | $192,868 | +201.2% | 28,156 | +242.6% | 0.00% | – |
| Q1 2023 | $64,026 | +13.1% | 8,219 | +10.5% | 0.00% | – |
| Q4 2022 | $56,603 | -0.7% | 7,438 | +5.4% | 0.00% | – |
| Q3 2022 | $57,000 | -14.9% | 7,054 | +1.9% | 0.00% | – |
| Q2 2022 | $67,000 | -4.3% | 6,924 | +38.7% | 0.00% | – |
| Q1 2022 | $70,000 | +2.9% | 4,993 | +50.5% | 0.00% | – |
| Q4 2021 | $68,000 | +183.3% | 3,317 | +206.6% | 0.00% | – |
| Q3 2021 | $24,000 | -65.2% | 1,082 | -63.9% | 0.00% | – |
| Q2 2021 | $69,000 | – | 3,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 1,472,331 | $7,052,465 | 2.91% |
| NEA Management Company, LLC | 7,692,298 | $36,846,107 | 2.85% |
| Octagon Capital Advisors LP | 812,895 | $3,893,767 | 0.60% |
| Alphabet Inc. | 1,464,015 | $7,012,631 | 0.45% |
| Avoro Capital Advisors LLC | 4,535,000 | $21,722,650 | 0.34% |
| Casdin Capital, LLC | 510,882 | $2,447,125 | 0.27% |
| Baker Brothers Advisors | 4,916,095 | $23,548,095 | 0.14% |
| Corton Capital Inc. | 14,460 | $69,263 | 0.04% |
| ExodusPoint Capital Management, LP | 619,248 | $2,966 | 0.03% |
| CORNERCAP INVESTMENT COUNSEL INC | 27,844 | $133,373 | 0.02% |